According to Merck's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.5545. At the end of 2022 the company had a P/S ratio of 4.75.
Year | P/S ratio | Change |
---|---|---|
2022 | 4.75 | 22.94% |
2021 | 3.86 | -10.49% |
2020 | 4.31 | -12.53% |
2019 | 4.93 | 5.25% |
2018 | 4.68 | 22.58% |
2017 | 3.82 | -6.29% |
2016 | 4.08 | 9.63% |
2015 | 3.72 | -2.54% |
2014 | 3.82 | 14.68% |
2013 | 3.33 | 26.93% |
2012 | 2.62 | 9.62% |
2011 | 2.39 | -0.99% |
2010 | 2.42 | -41.67% |
2009 | 4.14 | 53.66% |
2008 | 2.69 | -48.35% |
2007 | 5.22 | 24.95% |
2006 | 4.18 | 32.42% |
2005 | 3.15 | 1.89% |
2004 | 3.09 | 14.74% |
2003 | 2.70 | 9.6% |
2002 | 2.46 | -13.43% |
2001 | 2.84 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | 5.09 | 11.79% | ๐บ๐ธ USA |
![]() Novartis NVS | 3.76 | -17.40% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | 2.31 | -49.33% | ๐บ๐ธ USA |
![]() Abbott Laboratories ABT | 4.09 | -10.11% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | 11.5 | 151.60% | ๐บ๐ธ USA |
![]() Amgen AMGN | 4.96 | 8.83% | ๐บ๐ธ USA |
![]() Sanofi SNY | 2.85 | -37.34% | ๐ซ๐ท France |
![]() Bristol-Myers Squibb BMY | 3.16 | -30.66% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | 1.87 | -58.96% | ๐ฌ๐ง UK |
![]() Teva Pharmaceutical Industries TEVA | 0.6675 | -85.34% | ๐ฎ๐ฑ Israel |